Skip to main content
Article thumbnail
Location of Repository

HVEM Signalling Promotes Colitis

By Corinne Schaer, Stefanie Hiltbrunner, Bettina Ernst, Christoph Mueller, Michael Kurrer, Manfred Kopf and Nicola L. Harris
Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:3078914
Provided by: PubMed Central

Suggested articles

Citations

  1. (2005). A coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediator.
  2. (2008). A crucial role for HVEM and BTLA in preventing intestinal inflammation.
  3. (2008). A mouse-passaged dengue virus strain with reduced affinity for heparan sulfate causes severe disease in mice by establishing increased systemic viral loads.
  4. (2001). A peptide analogue of thrombin receptor-activating peptide inhibits thrombin and thrombin-receptor-activating peptide-induced vascular smooth muscle cell proliferation.
  5. (2005). B and T lymphocyte attenuator exhibits structural and expression polymorphisms and is highly Induced in anergic CD4+ T cells.
  6. (2008). CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator.
  7. (1993). Clinicopathologic study of dextran sulfate sodium experimental murine colitis.
  8. (2006). Cutting edge: B and T lymphocyte attenuator and programmed death receptor-1 inhibitory receptors are required for termination of acute allergic airway inflammation.
  9. (1996). Dextran sulfate sodium (DSS) induced experimental colitis in immunodeficient mice: effects in CD4(+) -cell depleted, athymic and NK-cell depleted SCID mice.
  10. (1994). Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice.
  11. (2001). Genomic characterization of LIGHT reveals linkage to an immune response locus on chromosome 19p13.3 and distinct isoforms generated by alternate splicing or proteolysis.
  12. (1998). Herpesvirus entry mediator ligand (HVEM-L), a novel ligand for HVEM/TR2, stimulates proliferation of T cells and inhibits HT29 cell growth.
  13. (2002). Induction of colitis in mice deficient of Peyer’s patches and mesenteric lymph nodes is associated with increased disease severity and formation of colonic lymphoid patches.
  14. (2004). LIGHT expression by mucosal T cells may regulate IFN-gamma expression in the intestine.
  15. (2005). LIGHT is constitutively expressed on T and NK cells in the human gut and can be induced by CD2-mediated signaling.
  16. (2006). LIGHT is dispensable for CD4+ and CD8+ T cell and antibody responses to influenza A virus in mice.
  17. (2000). LIGHT, a TNF-like molecule, costimulates T cell proliferation and is required for dendritic cell-mediated allogeneic T cell response.
  18. (2006). Lymphoid organ development: from ontogeny to neogenesis.
  19. (2002). Monoassociation of SCID mice with Helicobacter muridarum, but not four other enterics, provokes IBD upon receipt of T cells.
  20. (2006). NK-cell activation by LIGHT triggers tumor-specific CD8+ T-cell immunity to reject established tumors.
  21. (2000). Reciprocal expression of the TNF family receptor herpes virus entry mediator and its ligand LIGHT on activated T cells: LIGHT down-regulates its own receptor.
  22. (2008). Regulatory T cell expression of herpesvirus entry mediator suppresses the function of B and T lymphocyte attenuator-positive effector T cells.
  23. (2009). T cell intrinsic heterodimeric complexes between HVEM and BTLA determine receptivity to the surrounding microenvironment.
  24. (2009). T cell transfer model of chronic colitis: concepts, considerations, and tricks of the trade.
  25. (2005). Targeted deletion of metalloproteinase 9 attenuates experimental colitis in mice: central role of epithelial-derived MMP.
  26. (2002). Targeted disruption of LIGHT causes defects in costimulatory T cell activation and reveals cooperation with lymphotoxin beta in mesenteric lymph node genesis.
  27. (2008). Targeting lymphocyte activation through the lymphotoxin and LIGHT pathways.
  28. (2003). The lymphotoxin beta receptor is critically involved in controlling infections with the intracellular pathogens Mycobacterium tuberculosis and Listeria monocytogenes.
  29. (2000). The three HveA receptor ligands, gD, LT-alpha and LIGHT bind to distinct sites on HveA.
  30. (2001). The TNF superfamily members LIGHT and CD154 (CD40 ligand) costimulate induction of dendritic cell maturation and elicit specific CTL activity.
  31. (2002). TNF ligands and receptors in autoimmunity: an update.
  32. (2007). TREM-1–expressing intestinal macrophages crucially amplify chronic inflammation in experimental colitis and inflammatory bowel diseases.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.